Stay updated on ALKS 4230 and Pembrolizumab in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the ALKS 4230 and Pembrolizumab in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ALKS 4230 and Pembrolizumab in Head and Neck Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A new study version v3.6.0 was posted with a recruitment-status update indicating no longer looking for participants, and the previous version v3.5.5 was removed from the history.
    Difference
    0.4%
    Check dated 2026-06-15T08:42:34.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The record history now shows the latest revision as v3.5.5, replacing the previous v3.5.4 entry in the changes list.
    Difference
    0.1%
    Check dated 2026-06-08T04:24:54.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    An additional revision entry, v3.5.4, was added to the Study Record History, extending the version history after v3.5.3. The previous revision v3.5.3 has been removed from the current change set.
    Difference
    0.1%
    Check dated 2026-05-18T03:27:13.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page’s footer/site revision label has been updated from v3.5.2 to v3.5.3, indicating a minor platform/version change without altering the clinical trial record shown.
    Difference
    0.1%
    Check dated 2026-04-26T15:16:09.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and deleted Revision: v3.5.0 in the study record history.
    Difference
    0.1%
    Check dated 2026-04-19T12:44:27.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0; Removed Revision: v3.4.3 in the record history.
    Difference
    0.1%
    Check dated 2026-03-21T09:09:47.000Z thumbnail image

Stay in the know with updates to ALKS 4230 and Pembrolizumab in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ALKS 4230 and Pembrolizumab in Head and Neck Cancer Clinical Trial page.